This program was established in 2007 and was most recently re-accredited by ASHP in 2020. The program provides an environment to enhance pharmacotherapy skills in a variety of inpatient and outpatient settings through a health system with a clinical focus on hematological and oncological disorders. The PGY2 pharmacy residency program builds on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experiences and knowledge and incorporating both in the into the provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in oncology pharmacy.

Rotations for the PGY2 Hematology-Oncology Residency Program are:

• Medical Oncology-Inpatient (1 month)
• Medical Oncology-Outpatient (3 months)
• Hematology/Bone Marrow Transplant-Inpatient (1month)
• Blood and Marrow Transplant-Outpatient (1month)
• Infectious Diseases (1month)
• Palliative Care/Pain Management (2 weeks)
• Investigational Drug Service (2 weeks)
• Electives (2-3 months)
• Pharmacokinetics (Longitudinal)
• Inpatient Pharmacy and Cancer Center Staffing (Longitudinal)
• Oncology Administration (2 weeks)

The specific program for each resident varies based upon the resident’s goals, interests, and previous experience. All residents are required to complete the above core rotations, unless clinical competence can be demonstrated in the specific learning experience. Elective rotations can include another month in each of the listed rotation learning experiences or in palliative care, hospice, pediatric oncology, benign hematology, or investigational drug services.  An elective experience in the Teaching Certificate Program at Duquesne University School of Pharmacy is also available.

More information can be found at our website:

https://www.ahn.org/health-care-professionals/education/allied-health/pharmacy/allegheny-general 

Applicants to an AGH pharmacy residency program must have graduated from an accredited school of pharmacy, and be licensed or eligible for licensure in the state of Pennsylvania. Applicants to PGY2 programs must have graduated or be on track to graduate from an ASHP Accredited PGY1 program or a program seeking accreditation through ASHP.

Information on Pennsylvania pharmacist licensure eligibility can be found at http://www.dos.pa.gov/ProfessionalLicensing/BoardsCommissions/Pharmacy.

Applications will be accepted through January 2, 2020. Application materials should include the following:

• Letter of intent
• Residency Interest Form
• Curriculum vitae
• Three professional letters of recommendation
• Academic transcript

An on-site interview is also required. The residency commences by July 1.

Candidates must submit their application electronically via ASHP PhORCAS and also participate in the ASHP residency matching program.